www.astro.org
Abstract # 2023 A Phase I Trial of 111In-human Epidermal Growth Factor in Patients with Metastatic EGFR-positive Breast Cancer

Presenter: Vallis, Katherine

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos


Authors:
K. A. Vallis1, R. M. Reilly2, D. A. Scollard3, P. Merante4, M. Freeman5, G. Lockwood6, K. Sabate6, A. Brade7, 1Radiation Oncology and Biology, University of Oxford, Oxford OX3 7LJ, United Kingdom, 2Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada, 33Division of Nuclear Medicine, Toronto General Hospital Research Institute, Toronto, ON, Canada, 4Radiation Medicine Program, Princess Margaret Hospital, Toronto, ON, Canada, 5Department of Medical Imaging, University of Toronto, Toronto, ON, Canada, 6Biostatistics, Princess Margaret Hospital, Toronto, ON, Canada, 7Radiation Medicine Program, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

Author Disclosure:
 K.A. Vallis, None; R.M. Reilly, None; D.A. Scollard, None; P. Merante, None; M. Freeman, None; G. Lockwood, None; K. Sabate, None; A. Brade, None.


E-mail a friend about this abstract:
Enter email address: